Cart (0 Items)
Your cart is currently empty.
View ProductsSize | 100ug |
---|---|
Brand | Arovia |
Product type | Recombinant Proteins |
Product name | Recombinant Human NMT1 Protein, N-His |
---|---|
Origin species | Human |
Expression system | Prokaryotic expression |
Molecular weight | 47.50 kDa |
Buffer | Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol. |
Form | Liquid |
Delivery condition | Dry Ice |
Delivery lead time in business days | 3-5 days if in stock; 3-5 weeks if production needed |
Storage condition | 4°C for short term (1 week), -20°C or -80°C for long term (avoid freezing/thawing cycles; addition of 20-40% glycerol improves cryoprotection) |
Brand | Arovia |
Host species | Escherichia coli (E.coli) |
Fragment Type | Thr108-Gln496 |
Aliases /Synonyms | Myristoyl-CoA:protein N-myristoyltransferase 1, Type I N-myristoyltransferase, NMT 1, Peptide N-myristoyltransferase 1, NMT1, Glycylpeptide N-tetradecanoyltransferase 1, NMT |
Reference | ARO-P11812 |
Note | For research use only. |
Recombinant Human NMT1 Protein, also known as N-myristoyltransferase 1, is a key enzyme involved in the post-translational modification of proteins. This protein is encoded by the NMT1 gene and plays a crucial role in a variety of cellular processes, making it a valuable tool in scientific research and potential therapeutic applications.
The Recombinant Human NMT1 Protein is a 52 kDa protein consisting of 471 amino acids. It is composed of two domains – an N-terminal catalytic domain and a C-terminal myristoyl-binding domain. The catalytic domain is responsible for the transfer of myristic acid to the N-terminal glycine of target proteins, while the myristoyl-binding domain helps in the recognition and binding of target proteins.
The crystal structure of Recombinant Human NMT1 Protein has been determined, revealing its unique three-dimensional structure. This structure provides insights into the mechanism of action of this enzyme and aids in the design and development of inhibitors and modulators.
The primary function of Recombinant Human NMT1 Protein is to catalyze the transfer of myristic acid from myristoyl-CoA to the N-terminal glycine residue of target proteins. This modification, known as N-myristoylation, is essential for the proper functioning and localization of many proteins involved in signal transduction, membrane targeting, and protein-protein interactions.
Recombinant Human NMT1 Protein has been found to have a broad substrate specificity, with the ability to myristoylate a wide range of proteins. This includes viral proteins, such as HIV-1 Gag and Rous sarcoma virus Gag, as well as cellular proteins, such as the α subunit of G proteins and Src family kinases.
In addition to its role in protein myristoylation, Recombinant Human NMT1 Protein has been shown to have other activities as well. It has been found to have protein kinase activity, phosphorylating certain substrates in vitro. It has also been reported to have RNA binding activity, suggesting a potential role in RNA metabolism.
The unique structure and activity of Recombinant Human NMT1 Protein make it a valuable tool in scientific research and potential therapeutic applications. Some of its applications include:
Recombinant Human NMT1 Protein has been used to study the importance of N-myristoylation in various cellular processes, such as signal transduction, membrane targeting, and protein-protein interactions. Its ability to myristoylate a wide range of proteins makes it a useful tool in understanding the role of this modification in different biological pathways.
The crystal structure of Recombinant Human NMT1 Protein has aided in the design and development of inhibitors and modulators of this enzyme. These molecules can be used to study the function of NMT1 and its role in diseases, as well as potential therapeutic targets for conditions such as cancer and viral infections.
Recombinant Human NMT1 Protein can be used to produce myristoylated proteins in vitro. These proteins can then be used for various research purposes, such as structural studies, or as potential therapeutics for diseases where N-myristoylation plays a crucial role.
Mutations in the NMT1 gene have been linked to various diseases, such as cancer and neurodegenerative disorders.
Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.
Reviews
There are no reviews yet.